HPCM
ZBH icon

Hunter Perkins Capital Management’s Zimmer Biomet ZBH Stock Holding History

Hunter Perkins Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,060
Closed -$308K – 172
2020
Q4 		$308K Buy
+2,060
New +$291K 0.05% 144

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Hunter Perkins Capital Management's ZBH Position: Q1 2021 in Review

Hunter Perkins Capital Management sold out of Zimmer Biomet (ZBH) in Q1 2021, closing a stake of 2,060 shares — an estimated $308K sold.

Hunter Perkins Capital Management first reported a position in ZBH in Q4 2020 and held it in 1 quarter. The position peaked at $308K in Q4 2020. 1,029 funds tracked by Wall St. Rank hold ZBH as of Q1 2021.

  • Hunter Perkins Capital Management reported no remaining Zimmer Biomet position as of Q1 2021 after selling out during the quarter.
  • Hunter Perkins Capital Management sold 2,060 Zimmer Biomet shares in Q1 2021, an estimated $308K.
  • Hunter Perkins Capital Management first reported a position in Zimmer Biomet in Q4 2020 and held it in 1 quarter.
  • Hunter Perkins Capital Management's Zimmer Biomet position peaked at $308K in Q4 2020.
  • 1,029 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2021.

Based on Hunter Perkins Capital Management's 13F filing for Q1 2021, filed 28 Apr 2021.